Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 21;14(3):675.
doi: 10.3390/jcm14030675.

Safety and Outcomes of Catheter Ablation for Consecutive Atrial Tachycardia in Elderly Patients After Previous Cardiac Interventions

Affiliations

Safety and Outcomes of Catheter Ablation for Consecutive Atrial Tachycardia in Elderly Patients After Previous Cardiac Interventions

Ann-Kathrin Kahle et al. J Clin Med. .

Abstract

Background: Age is a relevant risk factor for the development of atrial arrhythmias and an independent predictor of adverse cardiovascular outcomes. The incidence of atrial tachycardia (AT) is known to increase with aging, but so far, there are no data on elderly patients with AT. Therefore, we sought to assess the safety and outcomes of AT ablation in patients ≥75 years compared to those <75 years. Methods: A total of 420 consecutive patients undergoing AT ablation after previous cardiac interventions (mean 2.1 ± 0.1 prior ablation procedures) were analyzed. Safety, as well as acute and mid-term outcomes of AT ablation were compared between 140 patients ≥75 years (mean age 78.1 ± 0.2 years, 22.9% aged ≥80 years (range 80-86 years)) and 280 patients <75 years (mean age 62.2 ± 0.6 years). Results: Patients ≥75 years were more often female (54.3% vs. 38.2%; p = 0.0024) and presented with more cardiac comorbidities, including arterial hypertension (85.0% vs. 64.3%; p < 0.0001) and coronary artery disease (33.6% vs. 18.2%; p = 0.0006). Acute success of AT ablation was reached in 96.4% vs. 97.9% of patients (p = 0.5173). Major complications (1.4% vs. 0.7%; p = 0.6035) and duration of hospital stay (2 (IQR 2-4) days vs. 2 (IQR 2-3) days; p = 0.9125) did not differ significantly between groups. During a follow-up of 364 (IQR 183-729.5) days, arrhythmia recurrences occurred in 45.0% vs. 49.3% (p = 0.4684), whereas repeat ablation was less frequently performed in patients ≥75 years (25.7% vs. 36.1%; p = 0.0361). Conclusions: AT ablation in patients ≥75 years after previous cardiac interventions in tertiary arrhythmia centers is safe and effective. Therefore, AT ablation should not be ruled out in elderly patients due to age alone, but should be considered based on arrhythmia burden, symptom severity and concomitant clinical and procedural risk factors.

Keywords: atrial fibrillation; atrial tachycardia; catheter ablation; elderly patients; electroanatomical mapping.

PubMed Disclaimer

Conflict of interest statement

A.-K.K. is an invited fellow of the Boston Scientific German Heart Rhythm Fellowship and has received an educational grant from Johnson & Johnson and travel grants from Abbott. F.-A.A. is an alumni fellow of the Boston Scientific German Heart Rhythm Fellowship, a speaker for Bristol Myers Squibb, and has received travel grants from Bayer Pharmaceuticals. C.M. has received fees as a speaker and for participating in advisory boards from Abbott, Bayer, Biotronik, Biosense Webster, BMS, Boston Scientific, Daiichi Sankyo, Philips Research Europe, and Pfizer. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

Figure 1
Figure 1
Elderly patients present with more cardiac comorbidities. Patients ≥75 years present more frequently with arterial hypertension, coronary artery disease, valvular disease, and with an implanted pacemaker compared to patients <75 years. aHTN = arterial hypertension; CAD = coronary artery disease. **** p < 0.0001; *** p < 0.001; * p < 0.05.
Figure 2
Figure 2
Procedural data, acute success, and major complications do not differ significantly between elderly and younger patients. (A) Procedural data and (B) acute procedural success and major complications do not differ significantly between patients ≥75 and <75 years. ns = not significant; RF = radiofrequency.
Figure 3
Figure 3
Repeat ablation is less frequently performed in elderly patients. Cumulative event-free survival probability curve illustrates freedom from (A) arrhythmia recurrence and (B) repeat ablation in patients ≥75 vs. <75 years. AF = atrial fibrillation; AT = atrial tachycardia. p values are based on the log-rank test.

Similar articles

References

    1. Eckardt L., Sehner S., Suling A., Borof K., Breithardt G., Crijns H., Goette A., Wegscheider K., Zapf A., Camm J., et al. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: The EAST-AFNET 4 trial. Eur. Heart J. 2022;43:4127–4144. doi: 10.1093/eurheartj/ehac471. - DOI - PMC - PubMed
    1. Hijazi Z., Lindbäck J., Alexander J.H., Hanna M., Held C., Hylek E.M., Lopes R.D., Oldgren J., Siegbahn A., Stewart R.A.H., et al. The ABC (age, biomarkers, clinical history) stroke risk score: A biomarker-based risk score for predicting stroke in atrial fibrillation. Eur. Heart J. 2016;37:1582–1590. doi: 10.1093/eurheartj/ehw054. - DOI - PMC - PubMed
    1. Krijthe B.P., Kunst A., Benjamin E.J., Lip G.Y.H., Franco O.H., Hofman A., Witteman J.C.M., Stricker B.H., Heeringa J. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur. Heart J. 2013;34:2746–2751. doi: 10.1093/eurheartj/eht280. - DOI - PMC - PubMed
    1. Akoum N., Mahnkopf C., Kholmovski E.G., Brachmann J., Marrouche N.F. Age and sex differences in atrial fibrosis among patients with atrial fibrillation. Europace. 2018;20:1086–1092. doi: 10.1093/europace/eux260. - DOI - PubMed
    1. Khurshid S., Choi S.H., Weng L.C., Wang E.Y., Trinquart L., Benjamin E.J., Ellinor P.T., Lubitz S.A. Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults. Circ. Arrhythm. Electrophysiol. 2018;11:e006273. doi: 10.1161/CIRCEP.118.006273. - DOI - PMC - PubMed

LinkOut - more resources